BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26681349)

  • 1. A Cost-Effectiveness Analysis of the Swedish Universal Parenting Program All Children in Focus.
    Ulfsdotter M; Lindberg L; Månsdotter A
    PLoS One; 2015; 10(12):e0145201. PubMed ID: 26681349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of parenting interventions for the prevention of behaviour problems in children.
    Nystrand C; Feldman I; Enebrink P; Sampaio F
    PLoS One; 2019; 14(12):e0225503. PubMed ID: 31790442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Stollenwerk B; Bartmus T; Klug F; Stock S; Müller D
    Osteoporos Int; 2015 Apr; 26(4):1367-79. PubMed ID: 25572047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient.
    Krummenauer F; Wolf C; Günther KP; Kirschner S
    Eur J Med Res; 2009; 14(2):76-84. PubMed ID: 19258217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
    Kaper J; Wagena EJ; van Schayck CP; Severens JL
    Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of childhood rotavirus vaccination in Germany.
    Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O
    Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach.
    Hofer F; Kauczor HU; Stargardt T
    Lung Cancer; 2018 Oct; 124():189-198. PubMed ID: 30268459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany.
    König HH; Barry JC
    Pediatrics; 2004 Feb; 113(2):e95-108. PubMed ID: 14754978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Four Parenting Programs and Bibliotherapy for Parents of Children with Conduct Problems.
    Sampaio F; Enebrink P; Mihalopoulos C; Feldman I
    J Ment Health Policy Econ; 2016 Dec; 19(4):201-212. PubMed ID: 27991419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece.
    Giannouchos TV; Mitsikostas DD; Ohsfeldt RL; Vozikis A; Koufopoulou P
    Clin Drug Investig; 2019 Oct; 39(10):979-990. PubMed ID: 31302899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective.
    Borgström F; Carlsson A; Sintonen H; Boonen S; Haentjens P; Burge R; Johnell O; Jönsson B; Kanis JA
    Osteoporos Int; 2006; 17(7):996-1007. PubMed ID: 16570118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.
    Bos JM; Rümke HC; Welte R; Spanjaard L; van Alphen L; Postma MJ
    Pharmacoeconomics; 2006; 24(2):141-53. PubMed ID: 16460135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial.
    Nohlert E; Helgason AR; Tillgren P; Tegelberg A; Johansson P
    Nicotine Tob Res; 2013 Sep; 15(9):1519-27. PubMed ID: 23404735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of case-based training for primary care physicians in evidence-based medicine of patients with coronary heart disease.
    Groot-Jensen S; Kiessling A; Zethraeus N; Björnstedt-Bennermo M; Henriksson P
    Eur J Prev Cardiol; 2016 Mar; 23(4):420-7. PubMed ID: 25896863
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.